Provide Current Location
Sign in to see your saved address

MACLEODS PHARMACEUTICALS

Mysoline Plus Tab 1 X10

₹ 50.40 / Piece

₹ 63

20%

Whatsapp
Facebook

Highlights

Primidone 250mg


⭐Important Notice⭐

* T & C Apply.
* Product MRP can be changed without prior notice.
* Product offer can be withdrawn, modified, and removed by the company without prior notice.
* Product images sometimes change based on stock availability.
* Delivery lead time can vary depending on traffic and availability.
* product availability as per location-wise stock matters.
* Please check the details of medicines Name, Strength, Quantity, Batch No., Expiry date, etc., with your prescription
Please understand that after accepting the medicines, we shall not be liable or responsible.
* Batch No., MRP, Expiry date, Image, description can be changed as per notice, etc.
* Any suppor,supportt please call/Whatsapp us ‪+91 8101099110‬.

Join WhatsApp Channel For Offer & Updates:-  https://whatsapp.com/channel/0029VagZBQk4yltHfZOmXQ0g

Mysoline Plus Tab 1 X 10 – Reliable Seizure Management Solution

Brand: MACLEODS PHARMACEUTICALS

Strength: 250mg (Primidone)

Introducing the Mysoline Plus Tab 1 X 10, a trusted pharmaceutical solution designed to help manage and control seizures effectively. Manufactured by MACLEODS PHARMACEUTICALS, this product is formulated with precision to provide consistent results for those in need of dependable seizure management. With Primidone 250mg as its active ingredient, Mysoline Plus is a choice that patients and healthcare professionals trust.

Why Choose Mysoline Plus Tab?

  • Effective Seizure Management: Contains Primidone 250mg, a well-researched and proven anticonvulsant, to help reduce seizure activity.
  • Trusted Brand: Made by MACLEODS PHARMACEUTICALS, a reputable name in the pharmaceutical industry.
  • Convenient Packaging: Comes in a 1 x 10 tablet strip, ensuring ease of use and accurate dosing.
  • Quality Assurance: Manufactured with strict quality controls to ensure safety and efficacy.

Important Notice